CAD (NASDAQ:ICAD) (market cap: $85.26M), a leader in AI-powered breast cancer detection, reported its third-quarter 2024 financial results, demonstrating a 4% year-over-year increase in revenue to $4.

CAD (ICAD) is advancing 5% in early trading despite today’s sharp downturn of the broader market. The company, whose products ...

Dana Brown, Chief Executive Officer, and Eric Lonnqvist, Chief Financial Officer, of iCAD will participate in one-on-one meetings with investors at the event. To request a meeting with iCAD ...

iCAD expects total revenue for the fourth quarter of 2024 to be between approximately $5.1 and $5.3 million. Dana Brown, Chief Executive Officer, and Eric Lonnqvist, Chief Financial Officer ...

On January 27, 2025, iCAD, Inc. (NASDAQ: ICAD) disclosed certain preliminary, unaudited financial information for the fourth quarter ending on December 31, 2024, alongside additional corporate ...

CAD to Participate in the BTIG at Snowbird:12th Annual MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceNASHUA, N.H., Jan.